The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes a number of changes that, if finalized, will ensure that Part D Medicare enrollees have access to more affordable prescription drugs and more robust prescription drug coverage at the pharmacy they prefer. The rule also gives health plans a new tool to combat the opioid crisis.
The proposed regulation also looks to eliminate DIR fees in the Medicare Part D Program. CMS is soliciting comment for applying some manufacturer rebates and all pharmacy price concessions to the price of a drug at the point of sale.
CMS will accept comments on the proposed rule until January 16, 2018.
For a fact sheet on the proposed rule, click here
Questions or Concerns?
Contact IPC’s Government Relations Team at: GovernmentRelations@ipcrx.com